유방 영상 진단 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 구성 요소, 용도, 최종 사용자, 기능, 솔루션, 모드

The global Breast Imaging Market is projected to grow from $5.6 billion in 2025 to $11.3 billion by 2035, at a compound annual growth rate (CAGR) of 7.3%. The breast imaging market continues to expand alongside increasing breast cancer screening programs and technological advancements. According to the World Health Organization (WHO), breast cancer became the most commonly diagnosed cancer globally, with approximately 2.3 million new cases annually. The International Agency for Research on Cancer (IARC) also reports rising screening demand across developed and emerging economies. Industry estimates indicate the global breast imaging market exceeded USD 5 billion in 2024 and is projected to grow at a CAGR of approximately 8% through 2032, supported by expanding digital mammography adoption, AI-enabled diagnostics, and government-funded early detection initiatives.

The product segment consists of multiple imaging modalities designed for breast cancer screening, diagnosis, treatment planning, and follow-up. Digital mammography systems dominate due to superior image quality, lower radiation exposure, and compatibility with artificial intelligence-assisted interpretation. Breast tomosynthesis systems continue gaining adoption by providing three-dimensional imaging that improves lesion detection in dense breast tissue. Breast ultrasound systems complement mammography by differentiating cystic and solid lesions, while breast MRI systems support high-risk patient assessment and preoperative planning. Breast PET and breast CT systems provide functional and high-resolution anatomical imaging for complex clinical cases. Continuous technological innovation, digital integration, and expanding screening initiatives are expected to sustain long-term demand.

The services segment supports the operational efficiency, regulatory compliance, and clinical performance of breast imaging equipment throughout its lifecycle. Installation services ensure accurate system deployment and calibration according to healthcare standards, while maintenance services minimize equipment downtime and extend operational life. Consultation services assist healthcare providers with workflow optimization, technology upgrades, and compliance with evolving imaging guidelines. Training services enable radiologists, technologists, and biomedical engineers to maximize diagnostic accuracy and equipment utilization. Increasing deployment of advanced digital imaging systems, growing outsourcing of equipment management, and emphasis on quality assurance continue to strengthen demand for comprehensive service offerings across healthcare facilities.

Geographical Overview

North America maintains a substantial share of the breast imaging market due to well-established diagnostic infrastructure, widespread insurance coverage, and organized breast cancer screening programs. The region benefits from high adoption of digital mammography, breast tomosynthesis, and AI-assisted diagnostic platforms across hospitals and outpatient imaging centers. Continuous equipment replacement cycles, strong presence of leading imaging manufacturers, favorable reimbursement frameworks, and ongoing investments in precision diagnostics reinforce market expansion. Government-supported awareness campaigns and comprehensive clinical guidelines encourage routine screening, while research collaborations accelerate commercialization of advanced breast imaging technologies throughout the healthcare ecosystem.

Asia-Pacific demonstrates significant market expansion driven by increasing healthcare expenditure, urbanization, and broader access to diagnostic imaging services. Governments across China, India, Japan, South Korea, and Southeast Asia continue investing in cancer screening infrastructure and public health initiatives aimed at early disease detection. Rapid installation of digital imaging systems, growing private diagnostic chains, and rising awareness regarding preventive healthcare are accelerating technology adoption. Expanding domestic manufacturing capabilities, favorable healthcare reforms, and increasing partnerships between global imaging companies and regional healthcare providers are expected to strengthen future market opportunities across both metropolitan and underserved healthcare settings.

Key Trends and Drivers

Advancements in 3D Breast Imaging Technologies:

The breast imaging market is experiencing significant growth due to advancements in 3D imaging technologies, such as digital breast tomosynthesis (DBT). These technologies provide enhanced visualization of breast tissues, allowing for more accurate detection of abnormalities compared to traditional 2D mammography. The improved diagnostic capabilities of 3D imaging are driving increased adoption among healthcare providers, as they seek to improve early detection rates and reduce false positives, ultimately leading to better patient outcomes.

Growing Focus on Early Detection Fueling Market Growth:

Increasing global incidence of breast cancer and expanding emphasis on early diagnosis continue to drive demand for advanced breast imaging technologies. Governments, healthcare organizations, and cancer awareness initiatives are promoting routine screening through national programs, resulting in greater utilization of mammography and complementary imaging modalities. Simultaneously, technological improvements delivering higher image quality, reduced radiation exposure, and improved diagnostic confidence encourage healthcare providers to modernize imaging infrastructure, supporting sustained investment across hospitals, diagnostic centers, and specialized breast care facilities.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Component
• 2.7 Key Market Highlights by Mode
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Mammography
  • 4.1.2 Breast Ultrasound
  • 4.1.3 Breast MRI
  • 4.1.4 Breast Tomosynthesis
  • 4.1.5 Nuclear Imaging
  • 4.1.6 Optical Imaging
  • 4.1.7 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Digital Mammography Systems
  • 4.2.2 Analog Mammography Systems
  • 4.2.3 Breast MRI Systems
  • 4.2.4 Breast Ultrasound Systems
  • 4.2.5 Breast PET Systems
  • 4.2.6 Breast CT Systems
  • 4.2.7 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Ionizing Imaging
  • 4.3.2 Non-Ionizing Imaging
  • 4.3.3 Others
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Screening
  • 4.4.2 Diagnostic
  • 4.4.3 Others
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Hospitals
  • 4.5.2 Diagnostic Centers
  • 4.5.3 Specialty Clinics
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Component (2020-2035)
  • 4.6.1 Hardware
  • 4.6.2 Software
  • 4.6.3 Services
  • 4.6.4 Others
• 4.7 Market Size & Forecast by Mode (2020-2035)
  • 4.7.1 Portable
  • 4.7.2 Stationary
  • 4.7.3 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 2D Imaging
  • 4.8.2 3D Imaging
  • 4.8.3 4D Imaging
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Image Analysis
  • 4.9.2 Workflow Solutions
  • 4.9.3 Data Management
  • 4.9.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 End User
    • 5.2.1.6 Component
    • 5.2.1.7 Mode
    • 5.2.1.8 Functionality
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 End User
    • 5.2.2.6 Component
    • 5.2.2.7 Mode
    • 5.2.2.8 Functionality
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 End User
    • 5.2.3.6 Component
    • 5.2.3.7 Mode
    • 5.2.3.8 Functionality
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 End User
    • 5.3.1.6 Component
    • 5.3.1.7 Mode
    • 5.3.1.8 Functionality
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 End User
    • 5.3.2.6 Component
    • 5.3.2.7 Mode
    • 5.3.2.8 Functionality
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 End User
    • 5.3.3.6 Component
    • 5.3.3.7 Mode
    • 5.3.3.8 Functionality
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 End User
    • 5.4.1.6 Component
    • 5.4.1.7 Mode
    • 5.4.1.8 Functionality
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 End User
    • 5.4.2.6 Component
    • 5.4.2.7 Mode
    • 5.4.2.8 Functionality
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 End User
    • 5.4.3.6 Component
    • 5.4.3.7 Mode
    • 5.4.3.8 Functionality
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 End User
    • 5.4.4.6 Component
    • 5.4.4.7 Mode
    • 5.4.4.8 Functionality
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 End User
    • 5.4.5.6 Component
    • 5.4.5.7 Mode
    • 5.4.5.8 Functionality
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 End User
    • 5.4.6.6 Component
    • 5.4.6.7 Mode
    • 5.4.6.8 Functionality
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 End User
    • 5.4.7.6 Component
    • 5.4.7.7 Mode
    • 5.4.7.8 Functionality
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 End User
    • 5.5.1.6 Component
    • 5.5.1.7 Mode
    • 5.5.1.8 Functionality
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 End User
    • 5.5.2.6 Component
    • 5.5.2.7 Mode
    • 5.5.2.8 Functionality
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 End User
    • 5.5.3.6 Component
    • 5.5.3.7 Mode
    • 5.5.3.8 Functionality
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 End User
    • 5.5.4.6 Component
    • 5.5.4.7 Mode
    • 5.5.4.8 Functionality
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 End User
    • 5.5.5.6 Component
    • 5.5.5.7 Mode
    • 5.5.5.8 Functionality
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 End User
    • 5.5.6.6 Component
    • 5.5.6.7 Mode
    • 5.5.6.8 Functionality
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 End User
    • 5.6.1.6 Component
    • 5.6.1.7 Mode
    • 5.6.1.8 Functionality
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 End User
    • 5.6.2.6 Component
    • 5.6.2.7 Mode
    • 5.6.2.8 Functionality
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 End User
    • 5.6.3.6 Component
    • 5.6.3.7 Mode
    • 5.6.3.8 Functionality
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 End User
    • 5.6.4.6 Component
    • 5.6.4.7 Mode
    • 5.6.4.8 Functionality
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 End User
    • 5.6.5.6 Component
    • 5.6.5.7 Mode
    • 5.6.5.8 Functionality
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Hologic
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 GE Healthcare
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Siemens Healthineers
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Philips Healthcare
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Fujifilm Holdings Corporation
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Canon Medical Systems Corporation
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Carestream Health
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Planmed Oy
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Konica Minolta
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Delphinus Medical Technologies
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Aurora Imaging Technology
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Dilon Technologies
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 SuperSonic Imagine
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 SonoCine
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 CureMetrix
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Volpara Health Technologies
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 iCAD Inc
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Koning Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 KUB Technologies
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Micrima
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us